|
1
|
Parkin DM, Ohshima H, Srivatanakul P and
Vatanasapt V: Cholangiocarcinoma: epidemiology, mechanisms of
carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev.
2:537–544. 1993.PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Welzel TM, Graubard BI, El-Serag HB, Shaib
YH, Hsing AW, Davila JA and McGlynn KA: Risk factors for
intrahepatic and extrahepatic cholangiocarcinoma in the United
States: a population-based case-control study. Clin Gastroenterol
Hepatol. 5:1221–1228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shaib YH, El-Serag HB, Nooka AK, Thomas M,
Brown TD, Patt YZ and Hassan MM: Risk factors for intrahepatic and
extrahepatic cholangiocarcinoma: a hospital-based case-control
study. Am J Gastroenterol. 102:1016–1021. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Albores-Saavedra J, Murakata L, Krueger JE
and Henson DE: Noninvasive and minimally invasive papillary
carcinomas of the extrahepatic bile ducts. Cancer. 89:508–515.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farges O and Fuks D: Clinical presentation
and management of intrahepatic cholangiocarcinoma. Gastroenterol
Clin Biol. 34:191–199. 2010. View Article : Google Scholar
|
|
7
|
Lim JH and Park CK: Pathology of
cholangiocarcinoma. Abdom Imaging. 29:540–547. 2004.
|
|
8
|
Gatto M and Alvaro D: New insights on
cholangiocarcinoma. World J Gastrointest Oncol. 2:136–145. 2010.
View Article : Google Scholar
|
|
9
|
Leelawat K, Narong S, Wannaprasert J and
Ratanashu-ek T: Prospective study of MMP7 serum levels in the
diagnosis of cholangiocarcinoma. World J Gastroenterol.
16:4697–4703. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seehofer D, Kamphues C and Neuhaus P:
Management of bile duct tumors. Expert Opin Pharmacother.
9:2843–2856. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Groen PC, Gores GJ, LaRusso NF,
Gunderson LL and Nagorney DM: Biliary tract cancers. N Engl J Med.
341:1368–1378. 1999.
|
|
12
|
Valk-Lingbeek ME, Bruggeman SW and van
Lohuizen M: Stem cells and cancer; the polycomb connection. Cell.
118:409–418. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lund AH and van Lohuizen M: Polycomb
complexes and silencing mechanisms. Curr Opin Cell Biol.
16:239–246. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mathews LA, Crea F and Farrar WL:
Epigenetic gene regulation in stem cells and correlation to cancer.
Differentiation. 78:1–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu DC and Yang ZL: Overexpression of EZH2
and loss of expression of PTEN is associated with invasion,
metastasis and poor progression of gallbladder adenocarcinoma.
Pathol Res Pract. 207:472–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Varambally S, Dhanasekaran SM, Zhou M,
Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt
RG, Otte AP, Rubin MA and Chinnaiyan AM: The polycomb group protein
EZH2 is involved in progression of prostate cancer. Nature.
419:624–629. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kleer CG, Cao Q, Varambally S, Shen R, Ota
I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS,
Livant D, Weiss SJ, Rubin MA and Chinnaiyan AM: EZH2 is a marker of
aggressive breast cancer and promotes neoplastic transformation of
breast epithelial cells. Proc Natl Acad Sci USA. 100:11606–11611.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jacobs JJ, Kieboom K, Marino S, DePinho RA
and van Lohuizen M: The oncogene and Polycomb-group gene bmi-1
regulates cell proliferation and senescence through the ink4a
locus. Nature. 397:164–168. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sasaki M, Yamaguchi J, Itatsu K, Ikeda H
and Nakanuma Y: Over-expression of polycomb group protein EZH2
relates to decreased expression of p16 INK4a in
cholangiocarcinogenesis in hepatolithiasis. J Pathol. 215:175–183.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoon KA, Gil HJ, Han J, Park J and Lee JS:
Genetic polymorphisms in the polycomb group gene EZH2 and the risk
of lung cancer. J Thorac Oncol. 5:10–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Messeguer X, Escudero R, Farré D, Núñez O,
Martinez J and Albà MM: PROMO: detection of known transcription
regulatory elements using species-tailored searches.
Bioinformatics. 18:333–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Farré D, Roset R, Huerta M, Adsuara JE,
Rosello L, Albà MM and Messeguer X: Identification of patterns in
biological sequences at the ALGGEN server: PROMO and MALGEN.
Nucleic Acids Res. 31:3651–3653. 2003.PubMed/NCBI
|
|
23
|
Barenboim M, Zoltick BJ, Guo Y and
Weinberger DR: MicroSNiPer: a web tool for prediction of SNP
effects on putative microRNA targets. Hum Mutat. 31:1223–1232.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rodriguez S, Gaunt TR and Day IN:
Hardy-Weinberg equilibrium testing of biological ascertainment for
Mendelian randomization studies. Am J Epidemiol. 169:505–514. 2009.
View Article : Google Scholar
|
|
25
|
Yoon JH, Higuchi H, Werneburg NW, Kaufmann
SH and Gores GJ: Bile acids induce cyclooxygenase-2 expression via
the epidermal growth factor receptor in a human cholangiocarcinoma
cell line. Gastroenterology. 122:985–993. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim EM, Kim JS, Choi MH, Hong ST and Bae
YM: Effects of excretory/secretory products from Clonorchis
sinensis and the carcinogen dimethylnitrosamine on the
proliferation and cell cycle modulation of human epithelial HEK293T
cells. Korean J Parasitol. 46:127–132. 2008.PubMed/NCBI
|
|
27
|
Zheng T, Wang J, Chen X, Meng X, Song X,
Lu Z, Jiang H and Liu L: Disruption of p73-MDM2 binding synergizes
with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma
cell line with p53 mutation. Tumour Biol. 31:287–295. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han C, Lim K, Xu L, Li G and Wu T:
Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdelta.
J Cell Biochem. 105:534–545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Issemann I and Green S: Activation of a
member of the steroid hormone receptor superfamily by peroxisome
proliferators. Nature. 347:645–650. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Evans RM: The steroid and thyroid hormone
receptor superfamily. Science. 240:889–895. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Youssef J and Badr M: Enhanced
hepatocarcinogenicity due to agonists of peroxisome
prolifer-atoractivated receptors in senescent rats: role of
peroxisome proliferation, cell proliferation and apoptosis.
ScientificWorldJournal. 2:1491–1500. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kliewer SA, Umesono K, Noonan DJ, Heyman
RA and Evans RM: Convergence of 9-cis retinoic acid and peroxisome
proliferator signalling pathways through heterodimer formation of
their receptors. Nature. 358:771–774. 1992. View Article : Google Scholar
|
|
33
|
Tugwood JD, Issemann I, Anderson RG,
Bundell KR, McPheat WL and Green S: The mouse peroxisome
proliferator activated receptor recognizes a response element in
the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J.
11:433–439. 1992.PubMed/NCBI
|
|
34
|
Chase A and Cross NC: Aberrations of EZH2
in cancer. Clin Cancer Res. 17:2613–2618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamaguchi J, Sasaki M, Sato Y, Itatsu K,
Harada K, Zen Y, Ikeda H, Nimura Y, Nagino M and Nakanuma Y:
Histone deacetylase inhibitor (SAHA) and repression of EZH2
synergistically inhibit proliferation of gallbladder carcinoma.
Cancer Sci. 101:355–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sasaki M, Ikeda H, Itatsu K, Yamaguchi J,
Sawada S, Minato H, Ohta T and Nakanuma Y: The overexpression of
polycomb group proteins Bmi1 and EZH2 is associated with the
progression and aggressive biological behavior of hepatocellular
carcinoma. Lab Invest. 88:873–882. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nakanuma Y, Sasaki M, Sato Y, Ren X, Ikeda
H and Harada K: Multistep carcinogenesis of perihilar
cholangiocarcinoma arising in the intrahepatic large bile ducts.
World J Hepatol. 1:35–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
